# Long-term efficacy and safety of dupilumab for severe bullous pemphigoid: A prospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-efficacy-and-safety-of-dupilumab-for-severe-bullous-pemphigoid-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dawei Huang,Yuexin Zhang,Yingyuan Yu,Yuxiong Jiang,Luyang Kong,Yangfeng Ding,Yuling Shi,Yunlu Gao |
| Citations | 18 |
| DOI | 10.1016/j.intimp.2023.111157 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.intimp.2023.111157 |
| OpenAlex ID | https://openalex.org/W4388326318 |
| PMID | 37925949 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Yuexin Zhang](https://scholariq.org/researchers/yuexin-zhang/)

## Paper journal

- [International Immunopharmacology](https://scholariq.org/journals/international-immunopharmacology/)

## Paper primary topic

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Paper topics

- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Genetic and rare skin diseases.](https://scholariq.org/topics/genetic-and-rare-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.